Cc1c(C)c2ccc(OC(C)C(=O)N3CC[C@@]4(O)CCCC[C@H]4C3)c(C)c2oc1=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?